Avance Clinical贊助全球Scrip獎項的中國生物製藥獎
Oct 27, 2022 08:00 HKT |  |
|
중국에서의 임상 연구 기회와 미국 식품의약국 승인 경로 – 백서
Oct 27, 2022 07:00 HKT |  |
|
Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE
Oct 26, 2022 19:00 HKT |  |
|
巨子生物已进入招股阶段：中国皮肤护理领军企业 年利润超8亿
Oct 26, 2022 12:32 HKT | |
|
巨子生物已進入招股階段：中國皮膚護理領軍企業 年利潤超8億
Oct 26, 2022 12:31 HKT | |
|
Giant Biogene has Entered Offering Stage: China's Leading Skin Treatment Company with Annual Profits of More Than RMB800 Million
Oct 26, 2022 12:30 HKT | |
|
中国的临床研究机会和美国食品药品监督管理局批准的途径 - 白皮书
Oct 26, 2022 07:00 HKT | |
|
中國的臨床研究機會和美國食品藥品監督管理局批准的途徑 - 白皮書
Oct 26, 2022 07:00 HKT | |
|
Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper
Oct 25, 2022 18:00 HKT | |
|
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round
Oct 20, 2022 14:45 HKT |  |
|
Sirnaomics将在未来两个行业学术会议上汇报GalAhead(TM)疗法递送平台及相关项目的最新进展
Oct 19, 2022 13:03 HKT | |
|
Sirnaomics將在未來兩個行業學術會議上匯報GalAhead(TM)療法遞送平台及相關項目的最新進展
Oct 19, 2022 13:02 HKT | |
|
Sirnaomics to Present Latest Developments on GalAhead(TM) Therapeutic Platform at Upcoming Industry Conferences
Oct 19, 2022 13:01 HKT | |
|
생명공학 분야 웨비나: 시장 동향, 우선 순위, 예측 및 FDA 승인 경로
Oct 19, 2022 06:00 HKT | |
|
아쿠라바이오, 글로벌 성장 프로그램 추진을 위해 유능한 고위 경영진 임명
Oct 19, 2022 06:00 HKT |  |
|
访中国抗体制药创办人梁瑞安：现是香港发展创科最好时候
Oct 18, 2022 13:30 HKT |  |
|
訪中國抗體製藥創辦人梁瑞安：現是香港發展創科最好時候
Oct 18, 2022 13:29 HKT | |
|
AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program
Oct 18, 2022 07:00 HKT | |
|
生物技术领域网络研讨会：市场趋势、优先事项、预测和 FDA 批准途径
Oct 17, 2022 13:00 HKT | |
|
生物技術領域網絡研討會：市場趨勢、優先事項、預測和 FDA 批准途徑
Oct 17, 2022 13:00 HKT | |
|